2021-11-16-世界卫生组织-Cervical_cancer_Nigeria_2021_country_profile_1页_64kb

Cervical Cancer Profile Summary for Nigeria

Morbidity and Mortality

• Crude incidence rate in 2020: 18.4 per 100,000 women.
• Cervical cancer deaths in 2019: 10,600 female deaths.
• Mortality-to-incidence ratio in 2020: 0.66.
• A population-based cancer registry is noted (2021).

Primary Prevention (HPV Vaccination)

• HPV vaccination program not included in national schedule.
• Introduction year: 2020. Estimated coverage: low.
• Coverage by age 15: not available. "*Programme coverage: % of national target population (among 9-14-year-old girls)", "*Coverage by age 15: % of population turning 15 that have been vaccinated".
• High-preformance screening coverage by age 35 or 45: not available. Source data suggests very low coverage (under 1%).
• Risk factors: Tobacco use prevalence (1.9%, 2020); HIV incidence (no recent data for women).

Secondary Prevention (Screening)

• No national cervical cancer screening program.
• Primary screening test used: not consistently detailed (text mentions screening methods).
• % of women aged 30-49 ever screened: 14%.
• % of women aged 30-49 screened in last 5 years: 11%.
• No defined referral system from primary care to higher levels noted (2021).

Treatment, Supportive Care & Infrastructure

• National management guidelines exist (2021).
• Radiotherapy/brachytherapy units: sparse (numbers per population).
• Healthcare professionals: Limited availability reported for oncologists, surgeons, radiologists, etc., leading to inadequate human resources.
• Palliative care for NCDs: Not specified for cancer in public system. Opioid consumption figures are ambiguous or unavailable.

WHO Elimination Strategy (Implicit Goals)

• Country-specific elimination targets and performance against them are illustrated in the text data, highlighting significant challenges in achieving goals (conflicting data points).